Navigation Links
Quanta BioSciences qRT-PCR technology recommended in newly published CDC protocol for detection of H7N9 Avian Influenza
Date:4/25/2013

GAITHERSBURG, Md., April 25, 2013 /PRNewswire/ -- Quanta BioSciences today announced the CDC Real-Time RT-PCR (rRT-PCR) Protocol LP-152 for Detection and Characterization of Avian A/H7 (Eurasian-lineage) Influenza recommends that public health and other qualified laboratories utilize Quanta's qScript One-Step qRT-PCR Kit, Low ROX (95059-200 and 95059-050).

According to the World Health Organization (WHO) 108 cases of H7N9 influenza have been reported in China, causing severe respiratory illness including 22 deaths, as of April 23. Whether person-to-person transmission of this virus is possible is unclear, but other strains of Avian Influenza A, such as H5N1, have been spread via human-to-human interaction. With the potential threat of pandemic presented by any flu virus that can spread human-to-human, it is imperative that the best technologies are employed to detect and characterize these viruses.

In an effort to make supply of the qScript One-Step qRT-PCR technology available across the globe in reaction to the H7N9 outbreak, Quanta BioSciences has engaged its worldwide distribution network to ensure steady supply. For more information on this technology or to determine how to source these kits, please visit http://www.quantabio.com/avianflu.

About Quanta Biosciences:

Quanta BioSciences Inc., a U.S. based company, supplies superior quality reagents for demanding RT and PCR applications in life science, drug discovery and public health laboratories around the world. The Quanta BioSciences PCR and cDNA synthesis reagent portfolio defines the standard for reproducibility, specificity and sensitivity in the quantitative PCR market. The qScript technology named in CDC protocol LP-152 is part of a large family of polymerases designed and built for robust quantitative amplification and detection.

Media Contact: Will Geist , Quanta BioSciences, +1 800-364-2149, ext. 702 or email will.geist@quantabio.com 


'/>"/>
SOURCE Quanta BioSciences
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Quantason Names Dr. Ellen B. Mendelson, Medical Director
2. Centrillion Biosciences Announces Next-Gen Sequencing Innovation Grant Program
3. Sangamo BioSciences Announces Presentation At The Needham Healthcare Conference
4. Sangamo BioSciences Announces Presentation At Regen Med Investor Day
5. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
6. Northstar Biosciences Launches All Natural Skincare Solutions
7. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
8. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research, Co-Invest in Sanguine BioSciences
9. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences
10. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
11. Nano3D Biosciences Releases 96-well BioAssembler for 3D Cell Culture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... ... different cell type. Many treatments for specific cancers, such as breast, prostate, or ... treatment is androgen deprivation therapy for advanced prostate cancer. , This therapy ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... microbe delivery system, announced it has secured $2M in funding from an impressive ... Angels, Carmen Innovations, and SVG Thrive Fund. With this investment, 3Bar is broadening ...
(Date:8/16/2017)... edition of the Inc. 5000 features a now-familiar name: BioPoint ( http://biopointinc.com/ ... list for the third year in a row. Now in its 36th ... a set of quantitative metrics. In addition, BioPoint was also named to ... Bay State . ... ...
(Date:8/15/2017)... 2017 After spending the past two years building a ... collection, GeneFo now offers this platform to healthcare stakeholders (hospitals, foundations, ... adherence, and data collection vis a vis their members, under their ... launch of this offer. ... ...
Breaking Biology Technology:
(Date:6/14/2017)... -- IBM (NYSE: IBM ) is introducing several innovative partner ... developing collaboration between startups and global businesses, taking place in ... event, nine startups will showcase the solutions they have built ... France is one of ... 30 percent increase in the number of startups created between ...
(Date:5/16/2017)... TEANECK, N.J. , May 16, 2017  Veratad ... leading provider of online age and identity verification solutions, ... the K(NO)W Identity Conference 2017, May 15 thru May ... Ronald Regan Building and International Trade Center. ... across the globe and in today,s quickly evolving digital ...
(Date:5/6/2017)... RAM Group , Singaporean based ... in biometric authentication based on a novel  ... to perform biometric authentication. These new sensors are based on ... Ram Group and its partners. This sensor will have ... and security. Ram Group is a next generation ...
Breaking Biology News(10 mins):